Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

NCT06947967 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, T-Cell, Peripheral

Interventions

DRUG: CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)
DRUG: Tucidinostat
DRUG: Placebo

Sponsor

Chipscreen Biosciences, Ltd.